Assignee
YANGTZE RIVER PHARM GROUP CO
CN·2 granted patents·1 pending application·2 citations·filing 2015–2020
Top patents by PatentIndex Score
3 records- 0163US9884870B2Polymorphic substance of yonkenafil hydrochloride, preparation method therefor, and composition and use thereofYANGTZE RIVER PHARM GROUP CO·Filed 2015·Granted Feb 6, 2018·2 cites·75 claims
- 0248US10947185B2Crystal form of dezocine and preparation method thereforYANGTZE RIVER PHARM GROUP CO·Filed 2018·Granted Mar 16, 2021·0 cites·16 claims
- 0341US2022117913A1Dezocine derivative and medical use thereofYANGTZE RIVER PHARM GROUP CO·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when YANGTZE RIVER PHARM GROUP CO files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →